Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease

Gut
S WrightL Lennard

Abstract

There are conflicting reports on the role of azathioprine (AZA) thioguanine nucleotide (TGN) metabolites in optimising therapy for inflammatory bowel disease (IBD). The aim of this study was to investigate TGN intrapatient variation, and the relationship between TGN concentrations and disease activity in IBD patients taking long term constant dose AZA. TGN and methylmercaptopurine nucleotide (MeMPN) concentrations were measured at intervals over a two year period. Disease activity was assessed at each clinic visit using the Crohn's disease activity index or Walmsley simple index for ulcerative colitis. Serial TGNs were measured in 159 patients (3-14 TGN assays, median 6). Intrapatient variation in TGN concentrations was 1-5-fold (median 1.6); the incidence of non-compliance was 13%. At the end of two years, 131 patients were evaluable at TGN steady state. Of this group, patients who remained in remission had significantly higher mean TGN concentrations than those patients who developed active disease (median TGNs 236 v 175, respectively; median difference 44 pmol (95% confidence interval 1-92); p = 0.04). MeMPN concentrations were not related to AZA efficacy or toxicity. This study has shown that lower TGN concentrations were l...Continue Reading

References

Jul 4, 1992·BMJ : British Medical Journal·A B HawthorneJ E Lennard-Jones
May 1, 1990·Diseases of the Colon and Rectum·A J LoboA T Axon
Oct 9, 1993·Lancet·E C Wright
May 8, 1993·BMJ : British Medical Journal·H A DaviesJ S Lilleyman
Nov 14, 1997·Clinical Pharmacology and Therapeutics·L D LewisD W Nierenberg
Oct 15, 1998·Gut·R S WalmsleyR N Allan
Sep 29, 2001·Kidney International·T E NevinsW Thomas
Nov 8, 2001·Journal of Pediatric Gastroenterology and Nutrition·P GuptaB S Kirschner
Mar 8, 2003·Alimentary Pharmacology & Therapeutics·K R HerrlingerE F Stange
Apr 17, 2003·The Journal of Clinical Investigation·Imke TiedeMarkus F Neurath

❮ Previous
Next ❯

Citations

Dec 6, 2005·Nature Clinical Practice. Gastroenterology & Hepatology·Matjaz HomanPetar Mamula
Nov 29, 2007·Nature Clinical Practice. Gastroenterology & Hepatology·Nanne K H de BoerChris J J Mulder
Mar 1, 2005·Journal of Pediatric Gastroenterology and Nutrition·Jeffrey S Hyams, James F Markowitz
Mar 23, 2013·Inflammatory Bowel Diseases·Anthony LopezLaurent Peyrin-Biroulet
Jul 29, 2005·Journal of Gastroenterology and Hepatology·Richard B Gearry, Murray L Barclay
Jul 30, 2008·Journal of Gastroenterology and Hepatology·Akira AndohYoshihide Fujiyama
Mar 8, 2013·World Journal of Gastroenterology : WJG·Pascal FreiGerhard Rogler
Apr 8, 2014·World Journal of Gastroenterology : WJG·Andres J YarurDaniel A Sussman
Nov 10, 2010·Inflammatory Bowel Diseases·Vincent BillioudLaurent Peyrin-Biroulet
Mar 9, 2012·Journal of Crohn's & Colitis·Giuseppe CostantinoWalter Fries
Jun 3, 2005·Current Opinion in Gastroenterology·Gert Van AsschePaul Rutgeerts
Sep 2, 2008·Expert Opinion on Drug Safety·Rupert Wl LeongMiles P Sparrow
Oct 6, 2010·Expert Opinion on Drug Metabolism & Toxicology·Pal Miheller, Peter Laszlo Lakatos
Aug 10, 2015·Clinical Pharmacokinetics·Mehmet CoskunOle Haagen Nielsen
Apr 20, 2010·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·P de GraafA I Veldkamp
Apr 7, 2016·Journal of Neuroimmunology·William RaeAshwin Pinto
Feb 10, 2009·Gastroentérologie Clinique Et Biologique·X RoblinL Peyrin-Biroulet
Oct 9, 2013·Alimentary Pharmacology & Therapeutics·J R GoodhandJ O Lindsay
Jun 21, 2005·Alimentary Pharmacology & Therapeutics·C A Siegel, B E Sands
Apr 28, 2009·Alimentary Pharmacology & Therapeutics·J P GisbertF Gomollón
Jun 27, 2007·Alimentary Pharmacology & Therapeutics·B BokemeyerM Schwab
Aug 22, 2006·Alimentary Pharmacology & Therapeutics·L J J DerijksD W Hommes
Jul 5, 2011·Alimentary Pharmacology & Therapeutics·Y González-LamaUNKNOWN "Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)"
Apr 11, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Harpreet K DhaliwalLynne Lennard
Dec 21, 2012·International Journal of Clinical Practice·M SmithJ Sanderson
Sep 21, 2011·Alimentary Pharmacology & Therapeutics·L ArmstrongR K Russell
Aug 22, 2013·British Journal of Clinical Pharmacology·Lynne Lennard
Jan 7, 2015·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Andres J YarurMaria T Abreu
May 15, 2015·Journal of Crohn's & Colitis·Shi Sum PoonSreedhar Subramanian
May 27, 2015·European Journal of Clinical Pharmacology·E G QuetglasSilvio Danese
Jun 20, 2014·Gut·Edouard LouisLaurent Beaugerie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.